Status:
COMPLETED
Increasing Engagement With Messages Regarding CRC Screening Among Adults Aged 45-49
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
UCLA Vatche and Tamar Manoukian Division of Digestive Diseases
Carnegie Mellon University
Conditions:
Colorectal Cancer
Colorectal Neoplasms
Eligibility:
All Genders
45-49 years
Phase:
NA
Brief Summary
In May of 2021, the United States Preventive Service Task Force (USPSTF) updated their colorectal cancer (CRC) screening guidelines by recommending screening at an earlier age for average-risk adults ...
Detailed Description
Colorectal cancer (CRC) is the second leading cause of cancer-related death for both men and women in the United States. One in 17 Americans will suffer from CRC during their lifetime and early detect...
Eligibility Criteria
Inclusion
- UCLA Health patient
- Age 45-49 (as of 2/1/2022)
- Active primary care provider
- Visit within the last 3 years
Exclusion
- Age \<45 or \>50 years old at time of randomization
- Documented family history of CRC in EMR
- History (personal or family) of prior adenomatous polyps in the EMR
- History of high-risk cancer syndromes (e.g., Lynch, FAP)
- Prior CRC screening with colonoscopy or FIT
- Inactive MyChart status at enrollment
- No documented SMS-capable phone number
Key Trial Info
Start Date :
February 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 21 2022
Estimated Enrollment :
20509 Patients enrolled
Trial Details
Trial ID
NCT05281159
Start Date
February 21 2022
End Date
November 21 2022
Last Update
November 13 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Health Department of Medicine, Quality Office
Westwood, Los Angeles, California, United States, 90095
2
UCLA Vatche and Tamar Manoukian Division of Digestive Diseases
Westwood, Los Angeles, California, United States, 90095